Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last kr167.50 SEK
Change Today -3.00 / -1.76%
Volume 35.9K
VITR On Other Exchanges
Symbol
Exchange
Stockholm
Frankfurt
As of 11:30 AM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

vitrolife ab (VITR) Snapshot

Open
kr171.00
Previous Close
kr170.50
Day High
kr171.50
Day Low
kr165.50
52 Week High
01/9/15 - kr185.00
52 Week Low
08/8/14 - kr103.75
Market Cap
3.6B
Average Volume 10 Days
56.0K
EPS TTM
kr5.46
Shares Outstanding
21.7M
EX-Date
05/6/15
P/E TM
30.7x
Dividend
kr1.50
Dividend Yield
0.60%
Current Stock Chart for VITROLIFE AB (VITR)

Related News

No related news articles were found.

vitrolife ab (VITR) Related Businessweek News

No Related Businessweek News Found

vitrolife ab (VITR) Details

Vitrolife AB (publ), a medical device company, develops, produces, and markets products and systems for assisted reproduction worldwide. It offers fertility products, including follicle aspiration needles, paraffin oil under the OVOIL brand, additional media for in vitro fertilization (IVF) procedures, labware products, vitrification products, and Primo Vision time-lapse embryo monitoring systems. The company’s fertility products also include G-series media, micromanipulation solutions, sperm processing solutions, micropipettes, and slow freezing products. It also provides cell therapy services to researchers and cell therapy companies. The company was formerly known as Scandinavian IVF Science and changed its name to Vitrolife AB (publ) in 1998. Vitrolife AB (publ) was founded in 1981 and is headquartered in Goteborg, Sweden.

332 Employees
Last Reported Date: 02/6/15
Founded in 1981

vitrolife ab (VITR) Top Compensated Officers

Chief Executive Officer
Total Annual Compensation: kr3.7M
Compensation as of Fiscal Year 2013.

vitrolife ab (VITR) Key Developments

Vitrolife AB (publ) Announces Consolidated and Parent Company Financial Results for the Fourth Quarter and Year Ended December 31, 2014

Vitrolife AB (publ) announced consolidated and parent company financial results for the fourth quarter and year ended December 31, 2014. For the quarter, on consolidated basis, the company reported net sales of SEK 136,859,000 against SEK 123,502,000 a year ago. Operating income was SEK 36,105,000 against SEK 21,724,000 a year ago. Net income attributable to parent company's shareholders was SEK 28,427,000 or SEK 1.39 per share against SEK 15,357,000 SEK 0.77 per share a year ago. Cash flow from operating activities was SEK 38,324,000 against SEK 37,651,000 a year ago. For the year, on consolidated basis, the company reported net sales of SEK 510,512,000 compared to SEK 452,738,000 a year ago. Operating income was SEK 143,346,000 against SEK 80,398,000 a year ago. Net income attributable to parent company's shareholders was SEK 109,109,000 or SEK 5.46 per share against SEK 56,274,000 or SEK 2.84 per share a year ago. Return on equity was 18.9% against 9.2% a year ago. Cash flow from operating activities was SEK 145,666,000 compared to SEK 106,127,000 for the same period last year. For the quarter, on parent company basis, the company reported operating loss of SEK 6,038,000 against SEK 1,401,000 a year ago. Loss after financial items was SEK 4,639,000 against SEK 4,342,000 a year ago. Net income was SEK 5,281,000 against SEK 904,000 a year ago. For the year, on parent company basis, the company reported operating loss of SEK 9,854,000 against SEK 5,801,000 a year ago. Loss after financial items was SEK 9,458,000 against SEK 8,111,000 a year ago. Net income was SEK 1,522,000 against net loss of SEK 2,036,000 a year ago.

Vitrolife Proposes Dividend for the Year 2014

The Board of Vitrolife proposed a dividend of SEK 1.50 per share for the year 2014.

Vitrolife AB (publ) to Report Fiscal Year 2014 Results on Feb 06, 2015

Vitrolife AB (publ) announced that they will report fiscal year 2014 results at 8:30 AM, Central European Standard Time on Feb 06, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VITR:SS kr167.50 SEK -3.00

VITR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bionet Corp 42.75 TWD -0.25
Cryo-Cell International Inc $2.50 USD -0.10
CryoLife Inc $9.99 USD -0.19
Osiris Therapeutics Inc $15.94 USD -0.39
Smith & Nephew PLC 1,168 GBp -16.00
View Industry Companies
 

Industry Analysis

VITR

Industry Average

Valuation VITR Industry Range
Price/Earnings 28.2x
Price/Sales 6.2x
Price/Book 4.8x
Price/Cash Flow 30.6x
TEV/Sales 6.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VITROLIFE AB, please visit www.vitrolife.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.